The encyclopedia · Legal & Compliance · Legal decision · 2007–2012
Chile's three pharmacy giants rigged medicine prices — emails exposed the pact
After a price war, Chile's top pharmacy chains secretly raised medicine prices in a coordinated '1-2-3' pattern — the court fined two of them US$19M each.
Farmacias Ahumada (FASA) · Farmacias Cruz Verde · Farmacias Salcobrand · 2012-01
What happened
Chile's pharmacy market had three big chains: Farmacias Ahumada, Cruz Verde and Salcobrand. After a price war in 2006–07 squeezed their margins, the three secretly agreed to stop competing. Between December 2007 and March 2008 they coordinated increases on more than 200 medicines, many of them cheap chronic-care drugs (Parkinson's, epilepsy, diabetes, asthma). The court later described the pattern as '1-2-3': one chain raised a price on day one, the next matched it on day two, the last on day three. In 79% of the increases, prices converged within a single day.
The pact unravelled in May 2008, when the Health Ministry publicly denounced the coordinated rises. The FNE, Chile's competition authority, opened an investigation, and the tribunal later reconstructed the agreement from executives' emails and price records. FASA confessed in March 2009, cooperated with the prosecutor, and settled for about US$1 million. Cruz Verde and Salcobrand denied the collusion for four years. In January 2012 the TDLC convicted both and imposed the maximum fine the law allowed: 20,000 UTA each — roughly US$19 million, about 3.5% of their 2007 pharmaceutical sales.
The scandal was public and political: protests and 'funas' — including stones and animal viscera thrown at stores — a boycott call for World Health Day 2009, criminal complaints against the chains, and a bill sent to Congress to punish collusion with prison. FASA's controlling family cashed out: the chain was sold to Mexico's Casa Saba in 2010 for US$637 million, passed to Alliance Boots in 2014, and returned to a group of Chilean investors in 2023.
Consumers waited 17 years for compensation. A class action filed by Sernac in 2013 ended in a US$2.6 million judgment against the three chains, and in August 2025 Farmacias Ahumada paid a further 980 million pesos (~US$1 million) to nearly 34,000 consumers under a final settlement. The case also inspired Chile's 'farmacias populares' — municipal, non-profit pharmacies that began in Recoleta in 2015.
Why it happened
- After a price war squeezed margins, the three chains chose collusion over competition: coordinated rises on more than 200 medicines, mostly cheap chronic-care drugs, in a '1-2-3' pattern.
- The pact left a paper trail. The tribunal reconstructed the agreement from executives' emails and price records — the same evidence the chains had denied existed.
- Cruz Verde and Salcobrand denied the facts for four years and earned the legal maximum fine. FASA confessed in 2009 and paid about US$1 million — a nineteenth of what denial cost.
- The chains misjudged the mood of the country: protests, boycotts and criminal complaints followed, and the case pushed a law to punish collusion with prison.
The lesson
Three chains ended a price war with a secret pact to raise medicine prices in turn. Emails exposed the '1-2-3' pattern — denial earned the maximum fine, confession a fraction of it.
Aftermath
Both convicted chains said they would appeal. FASA's owners sold out: the chain went to Mexico's Casa Saba in 2010 for US$637 million, then to Alliance Boots in 2014, and back to Chilean investors in 2023. Consumer compensation took 17 years — a 2013 class action ended in a US$2.6 million judgment, and in 2025 Farmacias Ahumada paid a further 980 million pesos to nearly 34,000 consumers. The scandal also spawned Chile's 'farmacias populares', municipal non-profit pharmacies, beginning in Recoleta in 2015.
Sources
- Colusión de precios en farmacias chilenas — Wikipedia (es)
- Farmacias Ahumada — Wikipedia (es)
- BioBioChile — Salco Brand y Cruz Verde reciben máxima condena por colusión: podrían pagar US$19 millones cada una, 31 Jan 2012
- BioBioChile — Quiénes recibirán la compensación de Farmacias Ahumada tras colusión, 7 Aug 2025
spotted an error? The club wants to know.
More like this
Loblaws led a bread price-fixing cartel for 14 years — then blamed a dead executive
YKK led a €328M zipper cartel — the world's biggest fastener maker rigged prices for years
Neutronfarma sold pills that treated everything — even COVID-19. Indecopi fined it
Somewhere, someone solved the problem this company failed at. 2nd Opinion →

Comments · 0
Sign in to join the comments.